Chipotle Mexican Grill: Time To Go Long

Da Shi Research
167 Followers

Summary

  • Chipotle Mexican Grill reported second-quarter results last week that showed the turnaround in the business remains firmly on track.
  • I have been waiting for the 2Q results and for the share price to drift down to the mid $300s to initiate a position in the stock.
  • Current fears surrounding the norovirus cases in Virginia are overblown and possibly being fanned by vested interests and short sellers.
  • For the long-term investor, the current share price of $350/share values the company in line with peers on a 2019 basis and cheaper post 2019.
  • Should CMG be able to generate similar operating margins by 2019 that it did pre E. coli, it could lift the price by well over 40% above current levels, pre re-rating.

Introduction

I wrote a piece on Chipotle Mexican Grill (NYSE:CMG) on July 3 following a precipitous fall in the share price the week before. You can read the report here.

In it, I suggested that the current share price of CMG was basically "priced for complete success," in that the implied financial performance over the coming couple of years that was at the time reflected in the share price back then brought the company's revenue/restaurant operating margin basically back to where it was pre the E. coli outbreak in last 2015.

This meant that any investor buying at then price ($420/share) was basically taking on all the risk that the company would, in the near term, regain the level of profitability and revenue growth that it enjoyed pre the E. coli outbreak, leaving no real margin or safety.

Since then, the share price has fallen some 19% and the company has released its 2Q17 results - 2 criteria that I suggested investors wait for before acquiring shares.

Source : Googlefinance

On the first criterion - the 2Q17 results - the company more or less disproved the hypothesis that it was going backwards. It generated comparable sales growth of over 8% and a restaurant level operating margin of 18.8% (compared to 15.5% in 2Q16 and 17.7% in Q117), well on the path to regaining the pre E. coli performance metrics. So a tick there.

On the second criteria, the much publicised "outbreak" (and I use that term very loosely) of norovirus on July 18 in one of the Virginia restaurants has caused panic amongst investors and has pushed the price down some 19% to 52-week lows. Three weeks ago, pre norovirus, I thought a price in the "mid to high 300s" made sense. I still do, so a tick there as well and have initiated an initial position in the stock.

This article was written by

167 Followers
I worked for over 20 years as an investment banker with a number of bulge bracket investment banks, working in many countries and mostly covering the natural resources space. I have an engineering and a finance degree. Im currently taking some time out from the industry to learn mandarin in Beijing. I remain passionate about investing - both as an interest and as a way of managing my own capital.

Analyst’s Disclosure: I am/we are long CMG. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About CMG Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on CMG

Related Stocks

SymbolLast Price% Chg
CMG
--